Oragenics Inc (NASDAQ:OGEN) shares are trading lower by 45.5% to $0.58 during Wednesday’s session after the company announced ...

Investment analysts at StockNews.com assumed coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the stock. Oragenics Stock ...

With over 5 million concussions occurring annually in the U.S. alone, there is a significant unmet need for effective diagnostic and therapeutic solutions. This partnership positions Oragenics and ...

Dec. 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN), a biotechnology company ... A and Series B Preferred Shares into common stock. The conversion helps simplify the company’s capital ...

Oragenics (OGEN) announced a strategic partnership with BRAINBox Solutions. This collaboration seeks to develop the first intranasal therapy ...

Equities research analysts at StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the stock. Oragenics ...

We have all of the hottest stock market news traders need to know about on Wednesday! That includes what’s going on with Oragenics (NYSEMKT:OGEN) stock, Beyond Meat (NASDAQ:BYND) stock and ...

On Tuesday, Oragenics Inc. (NYSE:OGEN) said it has completed a key study for its new concussion drug, ONP-002. What Happened: A recent study shows that the drug successfully targets areas inside ...